3.87 USD
-0.13 (-3.35%)
CCEL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. CCEL has a medium profitability rating, but doesn't score so well on its financial health evaluation. CCEL is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CCEL had negative earnings in the past year.
In the past year CCEL had a positive cash flow from operations.
CCEL had positive earnings in 4 of the past 5 years.
In the past 5 years CCEL always reported a positive cash flow from operatings.
1.2 Ratios
CCEL has a Return On Assets (-0.75%) which is in line with its industry peers.
With a decent Return On Invested Capital value of 7.64%, CCEL is doing good in the industry, outperforming 72.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CCEL is in line with the industry average of 9.44%.
The last Return On Invested Capital (7.64%) for CCEL is above the 3 year average (7.61%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROIC | 7.64% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
1.3 Margins
CCEL's Profit Margin has declined in the last couple of years.
The Operating Margin of CCEL (13.63%) is better than 84.00% of its industry peers.
In the last couple of years the Operating Margin of CCEL has declined.
The Gross Margin of CCEL (77.07%) is better than 91.00% of its industry peers.
CCEL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% |
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
2. Health
2.1 Basic Checks
CCEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CCEL has less shares outstanding than it did 1 year ago.
CCEL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CCEL has an improved debt to assets ratio.
2.2 Solvency
CCEL has an Altman-Z score of 0.08. This is a bad value and indicates that CCEL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.08, CCEL is not doing good in the industry: 79.00% of the companies in the same industry are doing better.
The Debt to FCF ratio of CCEL is 1.36, which is an excellent value as it means it would take CCEL, only 1.36 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.36, CCEL belongs to the top of the industry, outperforming 88.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Altman-Z | 0.08 |
ROIC/WACC0.66
WACC11.55%
2.3 Liquidity
CCEL has a Current Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEL's Current ratio of 0.63 is on the low side compared to the rest of the industry. CCEL is outperformed by 85.00% of its industry peers.
CCEL has a Quick Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEL has a Quick ratio of 0.60. This is amonst the worse of the industry: CCEL underperforms 82.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
CCEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 94.34%, which is quite impressive.
Measured over the past years, CCEL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -29.04% on average per year.
The Revenue has decreased by -0.29% in the past year.
The Revenue has been growing slightly by 0.11% on average over the past years.
EPS 1Y (TTM)94.34%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)-0.29%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-2.99%
3.2 Future
CCEL is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -202.32% yearly.
CCEL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.22% yearly.
EPS Next Y87%
EPS Next 2Y-202.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.55%
Revenue Next 2Y-3.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CCEL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CCEL. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCEL indicates a rather cheap valuation: CCEL is cheaper than 88.00% of the companies listed in the same industry.
CCEL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CCEL is cheaper than 97.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.04 | ||
| EV/EBITDA | 6.48 |
4.3 Compensation for Growth
A cheap valuation may be justified as CCEL's earnings are expected to decrease with -202.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-202.32%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CCEL has a Yearly Dividend Yield of 21.95%, which is a nice return.
Compared to an average industry Dividend Yield of 2.44, CCEL pays a better dividend. On top of this CCEL pays more dividend than 100.00% of the companies listed in the same industry.
CCEL's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 21.95% |
5.2 History
CCEL has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
The earnings of CCEL are negative and hence is the payout ratio. CCEL will probably not be able to sustain this dividend level.
DP-1109.12%
EPS Next 2Y-202.32%
EPS Next 3YN/A
NYSEARCA:CCEL (12/12/2025, 8:18:10 PM)
3.87
-0.13 (-3.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.19%
Inst Owner Change-0.69%
Ins Owners41.98%
Ins Owner Change2.25%
Market Cap31.19M
Revenue(TTM)31.75M
Net Income(TTM)-473.50K
Analysts43.33
Price Target8.67 (124.03%)
Short Float %0.13%
Short Ratio0.82
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 21.95% |
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP-1109.12%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)227.45%
Min EPS beat(2)178.43%
Max EPS beat(2)276.47%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.61%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-3.33%
Revenue beat(4)0
Avg Revenue beat(4)-2.41%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-2.16%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-125%
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.98 | ||
| P/FCF | 5.04 | ||
| P/OCF | 4.91 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.48 |
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)0.77
FCFY19.82%
OCF(TTM)0.79
OCFY20.37%
SpS3.94
BVpS-1.84
TBVpS-2.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROCE | 9.68% | ||
| ROIC | 7.64% | ||
| ROICexc | 8.24% | ||
| ROICexgc | 8.84% | ||
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% | ||
| FCFM | 19.48% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
ROICexc(3y)7.98%
ROICexc(5y)14.72%
ROICexgc(3y)8.63%
ROICexgc(5y)16.85%
ROCE(3y)9.64%
ROCE(5y)14.41%
ROICexgc growth 3Y-17.95%
ROICexgc growth 5Y-25.17%
ROICexc growth 3Y-16.74%
ROICexc growth 5Y-23.68%
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Debt/EBITDA | 1.54 | ||
| Cap/Depr | 17.31% | ||
| Cap/Sales | 0.54% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 119.5% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 0.08 |
F-Score7
WACC11.55%
ROIC/WACC0.66
Cap/Depr(3y)548.95%
Cap/Depr(5y)370.25%
Cap/Sales(3y)23.15%
Cap/Sales(5y)15.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.34%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-30.77%
EPS Next Y87%
EPS Next 2Y-202.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.29%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-2.99%
Revenue Next Year-1.55%
Revenue Next 2Y-3.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.52%
EBIT growth 3Y-9.92%
EBIT growth 5Y-12.52%
EBIT Next Year43.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y112.76%
FCF growth 3Y-15.98%
FCF growth 5Y-8.62%
OCF growth 1Y-20.62%
OCF growth 3Y-8.81%
OCF growth 5Y-1.01%
CRYO-CELL INTL INC / CCEL FAQ
What is the fundamental rating for CCEL stock?
ChartMill assigns a fundamental rating of 3 / 10 to CCEL.
Can you provide the valuation status for CRYO-CELL INTL INC?
ChartMill assigns a valuation rating of 2 / 10 to CRYO-CELL INTL INC (CCEL). This can be considered as Overvalued.
Can you provide the profitability details for CRYO-CELL INTL INC?
CRYO-CELL INTL INC (CCEL) has a profitability rating of 5 / 10.
What is the financial health of CRYO-CELL INTL INC (CCEL) stock?
The financial health rating of CRYO-CELL INTL INC (CCEL) is 3 / 10.